China Medical Technologies

China Medical Technologies, Inc. (NASDAQ:CMED) is a China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic ("IVD") products using Enhanced Chemiluminescence ("ECLIA") technology, Fluorescent in situ Hybridization ("FISH") technology and Surface Plasmon Resonance (“SPR”) technology to detect and monitor various diseases and disorders. The ECLIA business, which consists of ECLIA analyzer and reagent kits, is an IVD system based on ECLIA technology. The reagent kits are used to detect various thyroid disorders, diabetes, hepatitis, Down syndrome, liver fibrosis, disorders related to reproduction and growth and various types of tumors. The FISH business, which consists of FISH imaging...